Iluvien provides a continuous low-dose of steroids to treat diabetic macular edema. The treatment received FDA approval in 2014.
More articles on ASC issues:
10 best states for retirement
How to turn ASC staffing from a cost-center into a value center – 8 key steps
Healthcare services M&A: 10 key trends
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
